The warehouse floor is a numbers game, and the most expensive number is often the one for musculoskeletal injuries. Verve Motion, a Cambridge-based robotics startup, is betting that a soft, powered exosuit can change the math. Since its 2020 founding, the company has raised over $55 million to put its SafeLift suit on workers at major employers like Albertsons, UPS, and Wegmans [Simplify]. The pitch is straightforward: augment the human body, don't replace it, and turn a costly injury risk into a manageable capital expense.
A hardware wedge into industrial safety
Verve's product is a departure from the rigid, sci-fi exoskeletons of popular imagination. The SafeLift is a soft suit, using textiles and actuators to provide back and shoulder support during repetitive lifting. This design choice targets a specific buyer: the safety and operations managers at large-scale logistics, grocery distribution, and aviation companies. For them, the suit is not a robotics experiment but a piece of industrial personal protective equipment (PPE) with a clear return-on-injury calculation. The company's mission, as stated in a company profile, is to "power the human workplace through people-centric robotics" [MgmtBoston].
Why strategic investors are writing checks
The capital backing Verve Motion reveals a thesis about distribution as much as technology. Its $20 million Series B in late 2023 was led by deep-tech investor Safar Partners, with participation from Cybernetix Ventures and Construct Capital [TechCrunch, Dec 2023]. More telling are the strategic names on the cap table: industrial safety brands HexArmor and uvex group, and, as of July 2026, International Airlines Group (IAG) [IAG, Jul 2026]. These are not passive financial bets. They are channels. A PPE manufacturer can integrate the exosuit into its catalog; an airline group can mandate trials across its baggage handlers at British Airways, Iberia, and Vueling. This investor mix suggests Verve is building a route to market through established industrial ecosystems, a critical advantage for a hardware company selling into conservative, regulated environments.
The company's traction and team structure support this focused approach.
- Customer concentration. Early deployments are with massive, name-brand employers in logistics and grocery, a signal of product-market fit for a high-stakes, high-volume use case.
- Academic roots. As a Harvard University spin-off founded by researchers including Conor Walsh, a known figure in soft robotics, the company anchors its credibility in peer-reviewed biomechanics [Simplify].
- Commercial scaling. With a team reported at around 50 employees, the hiring emphasis has shifted toward commercial roles like regional sales managers, indicating a move from R&D to scaled deployment [MgmtBoston].
The counter-bet: automation over augmentation
The most direct challenge to Verve's model isn't a competing exosuit. It's full automation. In sectors like warehousing, the long-term trend points toward robots that pick, pack, and palletize, eliminating the human lift altogether. Verve's entire premise rests on the argument that this transition will be gradual, uneven, and economically irrational for the vast majority of existing facilities. The company is betting that for the next decade, it is cheaper and more practical to upgrade the worker than to rebuild the warehouse. This is a bet on the persistence of manual labor, a contrarian position in a robotics industry often obsessed with human replacement.
What the next funding round needs to prove
Verve Motion's estimated valuation crossed the $100 million mark following its 2023 Series B [Boston profile, Q4 2023]. The undisclosed investment from IAG in 2026 points to continued strategic interest. The questions for the next 12 to 18 months will be less about technology and more about unit economics and market expansion. Can the company demonstrate that its suits drive a measurable, auditable reduction in injury rates and workers' compensation costs for its flagship customers? Will the partnership with IAG unlock the highly regulated aviation sector as a new vertical? And can the hardware-software model,where the suit likely generates recurring revenue through data and service plans,achieve the margins venture-scale investors require? The $55 million from Safar Partners, Construct Capital, and industrial strategists has bought the runway. The landing will depend on proving that the suit isn't just protective equipment, but a fundamental tool for workforce productivity.
Sources
- [TechCrunch, Dec 2023] Verve Motion raises $20M Series B to expand exosuit production | https://techcrunch.com/2023/12/13/verve-motion-raises-20m-series-b-to-expand-exosuit-production/
- [Simplify] Verve Motion company and role description | https://simplify.jobs/p/verve-motion-b77a0641-4770-4966-896f-16132715783f
- [MgmtBoston] Verve Motion company profile | https://www.mgmtboston.com/companies/verve-motion
- [IAG, Jul 2026] IAG announces participation in Verve Motion's latest funding round | https://www.linkedin.com/posts/international-airlines-group_were-excited-to-announce-our-participation-in-activity-7215949544922370048-rC-T
- [Boston profile, Q4 2023] Estimated valuation profile for Verve Motion
- [The Robot Report, Dec 2023] Verve Motion raises $20M Series B for exosuits | https://www.therobotreport.com/verve-motion-raises-20m-series-b-for-exosuits/